Share buybacks · 2016–2025
Regeneron Pharmaceuticals share buybacks
$3.4B+32.1% · FY2025
Regeneron Pharmaceuticals (REGN) reported $3.4B in share buybacks for fiscal 2025, +32.1% year on year.
| Fiscal year | Share buybacks | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $3.4B | +32.1% | Open → |
| FY20242024-12-31 | $2.6B | +16.5% | Open → |
| FY20232023-12-31 | $2.2B | +7.3% | Open → |
| FY20222022-12-31 | $2.1B | +26.6% | Open → |
| FY20212021-12-31 | $1.6B | −71.9% | Open → |
| FY20202020-12-31 | $5.8B | +2,019.2% | Open → |
| FY20192019-12-31 | $276M | +6,170.5% | Open → |
| FY20182018-12-31 | $4.4M | +$4.4M | Open → |
| FY20172017-12-31 | $0 | $0 | Open → |
| FY20162016-12-31 | $0 | — | Open → |
Share buybacks — Share buybacks are the cash a company spent during the year repurchasing its own stock, taken from the financing section of the cash-flow statement. Most companies buy back nothing at all — the line is absent rather than zero — so this ranking covers the minority that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Share buybacks at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regeneron Pharmaceuticals share buybacks |url=https://companiesranked.com/en/company/regeneron-pharmaceuticals/share-buybacks |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regeneron Pharmaceuticals share buybacks. CompaniesRanked. https://companiesranked.com/en/company/regeneron-pharmaceuticals/share-buybacksBibTeX
@misc{companiesranked-en-company-regeneron-pharmaceuticals-share-buybacks-2026,
author = {{CompaniesRanked}},
title = {{Regeneron Pharmaceuticals share buybacks}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regeneron-pharmaceuticals/share-buybacks}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000872589-26-000008 · February 4, 2026
{{cite web |title=Regeneron Pharmaceuticals share buybacks — 10-K (0000872589-26-000008) |url=https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.